市場調査レポート

商品コード

1562471

感染症診断の市場規模、シェア、成長分析、製品・サービス別、検査タイプ別、サンプルタイプ別、疾患タイプ別、地域別 - 産業予測、2024年～2031年

Infectious Disease Diagnostics Market Size, Share, Growth Analysis, By Product & Service, By Type of Testing, By Sample Type, By Disease Type, By Region - Industry Forecast 2024-2031

出版日: 2024年09月11日
発行: SkyQuest
ページ情報: 英文 242 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

感染症診断の世界市場規模は、2022年に212億米ドルと評価され、2023年の229億4,000万米ドルから2031年には430億9,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは8.20%で成長する見通しです。

診断検査は、疾病の特定と世界の健康成果の向上に重要な役割を果たしています。感染症を診断する従来の方法は、時間がかかることが多く、不正確になりがちであったため、タイムリーで正確な検出には大きな課題があった。この制限が感染症診断市場の進歩の原動力となり、迅速、正確、携帯可能なポイントオブケア（POC）検査機器の開発につながった。POC検査は、検査プロセスを患者のいる場所に近づけることで迅速な診断を可能にし、結果を即座に提供します。この技術革新により、感染症検出の効率は大幅に改善され、緊急医療や遠隔地医療において特に価値が高まっています。その結果、現在多くの研究者が、複数の病原体を同時に検出できる多重ポイント・オブ・ケア診断技術の進歩に注力しています。これらの進歩は、より効率的で正確な検査の選択肢を提供し、感染症診断の状況を一変させつつあります。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

F. Hoffmann-La Roche Ltd.（Switzerland）
Abbott（US）
bioMerieux（France）
Siemens Healthineers AG（Germany）
Danaher（US）
Thermo Fisher Scientific Inc.（US）
Hologic, Inc.（US）
Becton, Dickinson and Company（US）
Revvity（US）
Qiagen（Netherlands）
Seegene Inc.（South Korea）
QuidelOrtho Corporation（US）
Grifols, S.A.（Spain）
DiaSorin S.p.A.（Italy）
Bio-Rad Laboratories, Inc.（US）
Sysmex Corporation（Japan）
OraSure Technologies（US）
Co-Diagnostics, Inc.（US）
Trinity Biotech（Ireland）
Genetic Signatures Ltd.（Australia）
Epitope Diagnostics, Inc.（US）
Trivitron Healthcare（India）
ELITech Group（France）
Meril Life Sciences Pvt. Ltd.（India）
InBios International, Inc.（US）
Uniogen Oy（Finland）
Vela Diagnostics（Singapore）

Product Code: SQMIG35G2215

Global Infectious Disease Diagnostics Market size was valued at USD 21.20 billion in 2022 and is poised to grow from USD 22.94 billion in 2023 to USD 43.09 billion by 2031, growing at a CAGR of 8.20% during the forecast period (2024-2031).

Diagnostic tests play a crucial role in identifying diseases and enhancing global health outcomes. Traditional methods for diagnosing infectious diseases were often time-consuming and prone to inaccuracies, which created significant challenges in timely and accurate detection. This limitation has driven advancements in the Infectious Disease Diagnostics Market, leading to the development of rapid, precise, and portable point-of-care (POC) testing devices. POC testing enables quicker diagnosis by bringing the testing process closer to the patient's location, delivering immediate results. This innovation has significantly improved the efficiency of infectious disease detection, making it especially valuable in urgent or remote healthcare settings. As a result, many researchers are now focused on advancing multiplex point-of-care diagnostic technologies, which can simultaneously detect multiple pathogens. These advancements are transforming the landscape of infectious disease diagnostics, offering more efficient and accurate testing options.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Infectious Disease Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Infectious Disease Diagnostics Market Segmental Analysis

Global Infectious Disease Diagnostics Market is segmented by Product & Service, Type of Testing, Sample Type, Disease Type, Technology, End User, and region. Based on Product & Service, the market is segmented into Reagents, Kits, And Consumables, Instruments, Software & Services. Based on Type of Testing, the market is segmented into Laboratory Testing, POC Testing. Based on Sample Type, the market is segmented into Blood, Serum, and Plasma, Urine, and Other Sample Types. Based on Disease Type, the market is segmented into Hepatitis, HIV, Hospital-acquired Infections, Mosquito-borne Diseases, HPV, Chlamydia Trachomatis, Neisseria Gonorrhea, Tuberculosis, Influenza, Syphilis, Other Infectious Diseases. Based on Technology, the market is segmented into Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-generation Sequencing, DNA Microarray, Other Technologies. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Infectious Disease Diagnostics Market

The rising prevalence of infectious diseases in both developed and developing regions is expected to positively influence the infectious disease diagnostics market. As more individuals seek diagnosis and treatment for such diseases, there has been a noticeable increase in prescriptions for diagnostic tests. This growing demand highlights the essential role of diagnostics in managing and addressing infectious health conditions. Additionally, the shift towards preventive medicine is further boosting the demand for infectious disease diagnostics. As healthcare providers and patients place greater emphasis on early detection and prevention, the use of diagnostic tests is anticipated to rise steadily over the forecast period. These combined factors are set to drive the market's expansion in the coming years.

Restraints in the Global Infectious Disease Diagnostics Market

Insufficient reimbursement poses a significant barrier to the growth of the infectious disease diagnostics market. Many diagnostic companies struggle with the challenge of securing coverage from health insurers for their tests, which complicates the commercialization process. This issue is particularly acute in developing countries, where a substantial portion of the population suffers from infectious diseases such as HIV, malaria, and tuberculosis. Additionally, the adoption of point-of-care (POC) kits in low- and middle-income countries is hindered by factors such as inadequate training for clinicians and limited product accessibility. These challenges are exacerbated by lower per capita healthcare expenditure in these regions, which contributes to the reduced uptake of advanced diagnostic technologies. As a result, addressing reimbursement issues and improving access and training are critical for enhancing the adoption of diagnostic solutions globally.

Market Trends of the Global Infectious Disease Diagnostics Market

Despite significant efforts in managing infectious diseases, there remains a strong demand for affordable, accurate, and sensitive point-of-care (POC) diagnostic products. The advent of nanotechnology has greatly contributed to advancements in this area, facilitating the development of innovative solutions in healthcare. Numerous companies are now focusing on integrating nanoparticles and nanodevices into POC platforms to meet this demand. These advancements in nanotechnology are enhancing the capabilities of diagnostic tools, making them more accessible and effective for widespread use in various healthcare settings.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Infectious Disease Diagnostics Market by Product & Service

Market Overview
Reagents, Kits, And Consumables
Instruments
Software & Services

Infectious Disease Diagnostics Market by Type of Testing

Market Overview
Laboratory Testing
POC Testing

Infectious Disease Diagnostics Market by Sample Type

Market Overview
Blood, Serum, And Plasma
Urine
Other Sample Types

Infectious Disease Diagnostics Market by Disease Type

Market Overview
Hepatitis
- Hepatitis B
- Hepatitis C
- Other Hepatitis Diseases
HIV
Hospital-acquired Infections
Mosquito-borne Diseases
HPV
Chlamydia Trachomatis
Neisseria Gonorrhea
Tuberculosis
Influenza
Syphilis
Other Infectious Diseases

Infectious Disease Diagnostics Market by Technology

Market Overview
Immunodiagnostics
Clinical Microbiology
Polymerase Chain Reaction
Isothermal Nucleic Acid Amplification Technology
DNA Sequencing & Next-generation Sequencing
DNA Microarray
Other Technologies

Infectious Disease Diagnostics Market by End User

Market Overview
Diagnostic Laboratories
Hospitals & Clinics
Academic Research Institutes
Other End Users

Infectious Disease Diagnostics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revvity (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seegene Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QuidelOrtho Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols, S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OraSure Technologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Co-Diagnostics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genetic Signatures Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Epitope Diagnostics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trivitron Healthcare (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ELITech Group (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meril Life Sciences Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InBios International, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Uniogen Oy (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vela Diagnostics (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

感染症診断の市場規模、シェア、成長分析、製品・サービス別、検査タイプ別、サンプルタイプ別、疾患タイプ別、地域別 - 産業予測、2024年～2031年

Infectious Disease Diagnostics Market Size, Share, Growth Analysis, By Product & Service, By Type of Testing, By Sample Type, By Disease Type, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

感染症診断市場：製品・サービス別

感染症診断市場：検査タイプ別

感染症診断市場：サンプルタイプ別

感染症診断市場：疾患タイプ別

感染症診断市場：技術別

感染症診断市場：エンドユーザー別

感染症診断市場規模：地域別